News - LOTUS PHARMACEUTICAL CO.,LTD

HOME > News

LOTUS News and news releases available from.

News & Topics

February　02, 2011

LOTUS and EPS Complete Agreement for OMS0728 in China.
LOTUS, EPS Co., Ltd. and TMRC Co., Ltd. announced that the parties completed a Sales Agreement of OMS0728 for the Chinese market. Under the terms of the agreement, LOTUS will develop OMS0728 and obtain its approval from SFDA , and EPS will obtain a sales right in the Chinese market.

October 12, 2010

October 12, 2010: 1st patient-in of OMS210 P2a clinical trials.

February 27, 2010

P2/3 clinical trials of OMS0728 begin in China.

October 04, 2010

P2a (POC) clinical trials of OMS210 for the treatment of IBS begin in 5 EU countries.

October 30, 2009

License-in contract of LTS1115 for its exclusive world-wide development, manufacturing and sales rights, and begin pre-clinical studies in Japan for target indication of autoimmune diseases including RA and SLE.

August 03, 2009

Move Head office to new address.

February 26, 2009

P1 multiple dose study of OMS210 begin in UK.

Copyright (c) LOTUS PHARMACEUTICAL CO.,LTD. All Rights Reserved.